Clinical trials
Active, not recruiting Phase 2 Lymphoma, Large B-Cell, Diffuse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 2 |
| David Bond, MD | 2 |
| Genmab | 2 |
| M.D. Anderson Cancer Center | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Cothera Bioscience, Inc | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 33 |
| Lymphoma, B-Cell | 7 |
| Lymphoma, Non-Hodgkin | 7 |
| Lymphoma | 5 |
| Recurrence | 5 |
| Lymphoma, Follicular | 4 |
| Neoplasms | 4 |
| Burkitt Lymphoma | 3 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Mantle-Cell | 3 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.